Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laney, A. S.
Right arrow Articles by Chang, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laney, A. S.
Right arrow Articles by Chang, Y.
(Chest. 2005;127:762-767.)
© 2005 American College of Chest Physicians

Kaposi Sarcoma-Associated Herpesvirus and Primary and Secondary Pulmonary Hypertension*

A. Scott Laney, MPH; Teresa De Marco, MD; Jonathan S. Peters, MS; Mary Malloy, MD; Carla Teehankee, BSc; Patrick S. Moore, MD and Yuan Chang, MD

* From the University of Pittsburgh Graduate School of Public Health (Mr. Laney and Mr. Peters), Pittsburgh, PA; University of California, San Francisco Cardiovascular Research Institute (Drs. De Marco and Malloy, and Ms. Teehankee), San Francisco, CA; and the Molecular Virology Program (Drs. Moore and Chang), University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, PA.

Correspondence to: Yuan Chang, MD, Molecular Virology Program, University of Pittsburgh Cancer Institute, Hillman Cancer Research Pavilion, Suite #1.8, 5117 Centre Ave, Pittsburgh, PA 15213; e-mail: yc70{at}pitt.edu

Background: Kaposi sarcoma-associated herpesvirus (KSHV) has been implicated as a factor in the pathogenesis of primary pulmonary hypertension (PPH). We conducted a case-control study of patients with PPH and pulmonary hypertension (PH) associated with other disorders (secondary PH) to look for evidence of KSHV infection.

Materials and methods: The study population was composed of patients with a diagnosis of PH at the University of California San Francisco Medical Center Department of Cardiology between July and November 2003. Serologic testing for KSHV was performed using enzyme-linked immunosorbent assays based on peptides from open reading frame-65 and K8.1, using sera from 19 patients with PPH, 29 patients with secondary PH, and 150 control subjects

Results: The overall seroprevalence of KSHV among all study participants was 2.0%. The rate among control subjects was 0.7% (1 of 150 subjects); among the study participants with PPH, we found no evidence of KSHV infection (0 of 19 patients). There was no significant difference between the observed seroprevalence of KSHV among patients with PPH compared to control subjects (p = 0.89). Of the 29 patients with a diagnosis of secondary PH, 3 patients (10.3%) were KSHV seropositive. Significantly, two of the three KSHV-infected secondary PH patients were also HIV positive, a known independent risk factor for KSHV infection and secondary PH.

Conclusion: Our data do not support KSHV infection having a significant role in PPH or non-HIV-associated secondary PH compared to age- and gender-matched control subjects.

Key Words: enzyme-linked immunosorbent assay • human herpesvirus-8 • K8.1 • Kaposi sarcoma-associated herpesvirus • open reading frame-65 • pulmonary hypertension




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
H. Katano and C. M. Hogaboam
Herpesvirus-associated Pulmonary Hypertension?
Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1485 - 1486.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. Henke-Gendo, M. Mengel, M. M. Hoeper, K. Alkharsah, and T. F. Schulz
Absence of Kaposi's Sarcoma-associated Herpesvirus in Patients with Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1581 - 1585.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
D. Montani, L. Achouh, A. G. Marcelin, J-P. Viard, O. Hermine, D. Canioni, O. Sitbon, G. Simonneau, and M. Humbert
Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease
Eur. Respir. J., November 1, 2005; 26(5): 969 - 972.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

Kaposi sarcoma-associated herpesvirus in primary and secondary pulmonary hypertension
Norbert F. Voelkel, et al.
Chest Online, 7 Jul 2005 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Chest Physicians.